Coverage policy updates

Policy changes Backwork has recorded, newest first. The most recent change on record is from October 14, 2026. Changes appear here after Backwork reviews and applies a refresh, so this page can trail the payers’ own sites.

Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.

Recorded changes

83,427 on record

Recorded policy changes, newest first
Recorded	Payer	Policy	Change
Aug 2, 2026	Noridian Healthcare Solutions	MolDX: Prostate Cancer Genomic Classifier Assay for Men with Localized DiseaseLCD · NORIDIAN-JE-L38339	New policy
Aug 2, 2026	Noridian Healthcare Solutions	MolDX: PrometheusÂ® IBD sgi DiagnosticÂ® PolicyLCD · NORIDIAN-JE-L37299	Codes changed
Aug 2, 2026	Noridian Healthcare Solutions	MolDX: PrometheusÂ® IBD sgi DiagnosticÂ® PolicyLCD · NORIDIAN-JE-L37299	New policy
Aug 2, 2026	Noridian Healthcare Solutions	MolDX: Prognostic and Predictive Molecular Classifiers for Bladder CancerLCD · NORIDIAN-JE-L38647	Codes changed
Aug 2, 2026	Noridian Healthcare Solutions	MolDX: Prognostic and Predictive Molecular Classifiers for Bladder CancerLCD · NORIDIAN-JE-L38647	New policy
Aug 2, 2026	Noridian Healthcare Solutions	MolDX: Predictive Classifiers for Early Stage Non-Small Cell Lung CancerLCD · NORIDIAN-JE-L38327	Codes changed
Aug 2, 2026	Noridian Healthcare Solutions	MolDX: Predictive Classifiers for Early Stage Non-Small Cell Lung CancerLCD · NORIDIAN-JE-L38327	New policy
Aug 2, 2026	Noridian Healthcare Solutions	MolDX: Plasma-Based Genomic Profiling in Solid TumorsLCD · NORIDIAN-JE-L39230	Codes changed
Aug 2, 2026	Noridian Healthcare Solutions	MolDX: Plasma-Based Genomic Profiling in Solid TumorsLCD · NORIDIAN-JE-L39230	New policy
Aug 2, 2026	Noridian Healthcare Solutions	MolDX: Pigmented Lesion AssayLCD · NORIDIAN-JE-L38151	Codes changed
Aug 2, 2026	Noridian Healthcare Solutions	MolDX: Pigmented Lesion AssayLCD · NORIDIAN-JE-L38151	New policy
Aug 2, 2026	Noridian Healthcare Solutions	MolDX: Pharmacogenomics TestingLCD · NORIDIAN-JE-L38335	Codes changed
Aug 2, 2026	Noridian Healthcare Solutions	MolDX: Pharmacogenomics TestingLCD · NORIDIAN-JE-L38335	New policy
Aug 2, 2026	Noridian Healthcare Solutions	MolDX: Oncotype DXÂ® Breast Cancer for DCIS (Genomic Healthâ¢)LCD · NORIDIAN-JE-L36941	Codes changed
Aug 2, 2026	Noridian Healthcare Solutions	MolDX: Oncotype DXÂ® Breast Cancer for DCIS (Genomic Healthâ¢)LCD · NORIDIAN-JE-L36941	New policy
Aug 2, 2026	Noridian Healthcare Solutions	MolDX: NRAS Genetic TestingLCD · NORIDIAN-JE-L36335	Codes changed
Aug 2, 2026	Noridian Healthcare Solutions	MolDX: NRAS Genetic TestingLCD · NORIDIAN-JE-L36335	New policy
Aug 2, 2026	Noridian Healthcare Solutions	MolDX: Non-Next Generation Sequencing Tests for the Diagnosis of BCR-ABL Negative Myeloproliferative NeoplasmsLCD · NORIDIAN-JE-L39923	Codes changed
Aug 2, 2026	Noridian Healthcare Solutions	MolDX: Non-Next Generation Sequencing Tests for the Diagnosis of BCR-ABL Negative Myeloproliferative NeoplasmsLCD · NORIDIAN-JE-L39923	New policy
Aug 2, 2026	Noridian Healthcare Solutions	MolDX: Next-Generation Sequencing Lab-Developed Tests for Myeloid Malignancies and Suspected Myeloid MalignanciesLCD · NORIDIAN-JE-L38123	Codes changed
Aug 2, 2026	Noridian Healthcare Solutions	MolDX: Next-Generation Sequencing Lab-Developed Tests for Myeloid Malignancies and Suspected Myeloid MalignanciesLCD · NORIDIAN-JE-L38123	New policy
Aug 2, 2026	Noridian Healthcare Solutions	MolDX: Next-Generation Sequencing for Solid TumorsLCD · NORIDIAN-JE-L38119	Codes changed
Aug 2, 2026	Noridian Healthcare Solutions	MolDX: Next-Generation Sequencing for Solid TumorsLCD · NORIDIAN-JE-L38119	New policy
Aug 2, 2026	Noridian Healthcare Solutions	MolDX: Molecular Testing for Risk Stratification of Thyroid NodulesLCD · NORIDIAN-JE-L39682	Codes changed
Aug 2, 2026	Noridian Healthcare Solutions	MolDX: Molecular Testing for Risk Stratification of Thyroid NodulesLCD · NORIDIAN-JE-L39682	New policy
Aug 2, 2026	Noridian Healthcare Solutions	MolDX: Molecular Testing for Solid Organ Allograft RejectionLCD · NORIDIAN-L40060	Codes changed
Aug 2, 2026	Noridian Healthcare Solutions	MolDX: Molecular Testing for Solid Organ Allograft RejectionLCD · NORIDIAN-L40060	New policy
Aug 2, 2026	Noridian Healthcare Solutions	MolDX: Molecular Testing for Identification and Management of Hereditary Transthyretin AmyloidosisLCD · NORIDIAN-JE-L39948	Codes changed
Aug 2, 2026	Noridian Healthcare Solutions	MolDX: Molecular Testing for Identification and Management of Hereditary Transthyretin AmyloidosisLCD · NORIDIAN-JE-L39948	New policy
Aug 2, 2026	Noridian Healthcare Solutions	MolDX: Molecular Testing for Detection of Upper Gastrointestinal Metaplasia, Dysplasia, and NeoplasiaLCD · NORIDIAN-JE-L39262	Codes changed
Aug 2, 2026	Noridian Healthcare Solutions	MolDX: Molecular Testing for Detection of Upper Gastrointestinal Metaplasia, Dysplasia, and NeoplasiaLCD · NORIDIAN-JE-L39262	New policy
Aug 2, 2026	Noridian Healthcare Solutions	MolDX: Molecular Syndromic Panels for Infectious Disease Pathogen Identification TestingLCD · NORIDIAN-JE-L39001	Codes changed
Aug 2, 2026	Noridian Healthcare Solutions	MolDX: Molecular Syndromic Panels for Infectious Disease Pathogen Identification TestingLCD · NORIDIAN-JE-L39001	New policy
Aug 2, 2026	Noridian Healthcare Solutions	MolDX: Molecular Biomarkers to Risk-Stratify Patients at Increased Risk for Prostate CancerLCD · NORIDIAN-JE-L39005	Codes changed
Aug 2, 2026	Noridian Healthcare Solutions	MolDX: Molecular Biomarkers to Risk-Stratify Patients at Increased Risk for Prostate CancerLCD · NORIDIAN-JE-L39005	New policy
Aug 2, 2026	Noridian Healthcare Solutions	MolDX: Molecular Biomarkers for Risk Stratification of Indeterminate Pulmonary Nodules Following BronchoscopyLCD · NORIDIAN-JE-L39678	Codes changed
Aug 2, 2026	Noridian Healthcare Solutions	MolDX: Molecular Biomarkers for Risk Stratification of Indeterminate Pulmonary Nodules Following BronchoscopyLCD · NORIDIAN-JE-L39678	New policy
Aug 2, 2026	Noridian Healthcare Solutions	MolDX: Molecular Biomarker Testing to Guide Targeted Therapy Selection in Rheumatoid ArthritisLCD · NORIDIAN-JE-L39467	Codes changed
Aug 2, 2026	Noridian Healthcare Solutions	MolDX: Molecular Biomarker Testing to Guide Targeted Therapy Selection in Rheumatoid ArthritisLCD · NORIDIAN-JE-L39467	New policy
Aug 2, 2026	Noridian Healthcare Solutions	MolDX: Molecular Biomarker Testing for Risk Stratification of Cutaneous Squamous Cell CarcinomaLCD · NORIDIAN-JE-L39589	Codes changed
Aug 2, 2026	Noridian Healthcare Solutions	MolDX: Molecular Biomarker Testing for Risk Stratification of Cutaneous Squamous Cell CarcinomaLCD · NORIDIAN-JE-L39589	New policy
Aug 2, 2026	Noridian Healthcare Solutions	MolDX: Molecular Assays for the Diagnosis of Cutaneous MelanomaLCD · NORIDIAN-JE-L39373	Codes changed
Aug 2, 2026	Noridian Healthcare Solutions	MolDX: Molecular Assays for the Diagnosis of Cutaneous MelanomaLCD · NORIDIAN-JE-L39373	New policy
Aug 2, 2026	Noridian Healthcare Solutions	MolDX: Minimal Residual Disease Testing for CancerLCD · NORIDIAN-JE-L38814	Codes changed
Aug 2, 2026	Noridian Healthcare Solutions	MolDX: Minimal Residual Disease Testing for CancerLCD · NORIDIAN-JE-L38814	New policy
Aug 2, 2026	Noridian Healthcare Solutions	MolDX: MGMT Promoter Methylation AnalysisLCD · NORIDIAN-JE-L36188	Codes changed
Aug 2, 2026	Noridian Healthcare Solutions	MolDX: MGMT Promoter Methylation AnalysisLCD · NORIDIAN-JE-L36188	New policy
Aug 2, 2026	Noridian Healthcare Solutions	MolDX: Melanoma Risk Stratification Molecular TestingLCD · NORIDIAN-JE-L37750	Codes changed
Aug 2, 2026	Noridian Healthcare Solutions	MolDX: Melanoma Risk Stratification Molecular TestingLCD · NORIDIAN-JE-L37750	New policy
Aug 2, 2026	Noridian Healthcare Solutions	MolDX: Lab-Developed Tests for Inherited Cancer Syndromes in Patients with CancerLCD · NORIDIAN-JE-L38972	Codes changed